Default company panoramic image
Medudem sep 15 letzte version gross grau services ohne schatten

MEDUDEM Corp.

We create the world’s first, ready to use and secured web based service, which catalyses, assures and simplifies the way healthcare participants collaborate.

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location 8001 Zurich, ZH, Switzerland
  • Currency CHF
  • Founded September 2007
  • Employees 6
  • Incorporation Type C-corp
  • Website careintegrator.com

Company Summary

MEDUDEM® links content providers with healthcare professionals and patients by means of a simple Webbrowser in an easy and efficient way. Amongst numerous interactions, this allows distribution of content, building health networks and setup of homecare collaborations between healthcare professionals and patients. We empower healthcare participants to better connect, communicate and collaborate.

Team

  • Default avatar
    Urs Wittwer

    Sept. 06 – to date: Founder and President of the Board of Startup MEDUDEM Corp.

    Aug. 05 – Sept. 06: Strategic Business Consultant for Medela Holding
    Aug. 04 – July 05: Business Unit Manager Dialysis, Baxter Corp.
    2001 – 2004: Marketing Director Autoimmunity & Allergy Pharmacia
    1999 – 2001: Sales Director Autoimmunity & Allergy Pharmacia
    1997 – 1999: Product Manager Autoimmunity Pharmacia
    Degrees: Biology, MBA Un. of St. Gall

  • Default avatar
    Martin Denz
    Dr. med.

    Doktor med.; President of the European Telemedicine Association, President of the Swiss Telemedicine Association; Founder of the Health advice Network of the University Hospital of Zurich

  • Default avatar
    Mario Jenni

    Product and Marketing Manager in different Healthcare companies; President of the Multicluster Biotech Market in Zurich

Advisors

  • Default avatar
    VISCHER ZURICH
    Lawyer
    Unconfirmed
    Default avatar
    BURCKHARDT
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Bank of Zurich
    Unconfirmed
    Default avatar
    Private Investors
    Unconfirmed